Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia

Blom, D. J., Averna, M. R., Meagher, E. A., Toit Theron, H. D., Sirtori, C. R., Hegele, R. A., … Cuchel, M. (2017, July 18). Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia. Circulation. Lippincott Williams and Wilkins. https://doi.org/10.1161/CIRCULATIONAHA.117.028208